In addition to cytokine-driven activation, tumor-derived cachexia-inducing factors [such as IL-6, LIF, and G-CSF (59, 60)] and immune cells within the tumor microenvironment secrete active molecules that further enhance STAT3 activation, thereby promoting muscle atrophy. The gene discussed is STAT3; the disease is neoplasm.